Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 288 results for "ranbaxy laboratories"

No decision on plant closures but will optimise network: Sun Pharma
Business Standard

No decision on plant closures but will optimise network: Sun P...

Sun Pharmaceutical Industries, which recently completed a $3.2-billion acquisition of Ranbaxy Laboratories, is considering rationalising its manufacturing network. Of the combined entity's 45 manufacturing plants, 21 are Ranbaxy's. Chief Financial ... Smart Investor, 11 hours ago

35 images for ranbaxy laboratories

Moneycontrol.com, 1 week ago
moneycontrol.com, 2 weeks ago
India Infoline, 1 month ago
Sify, 1 month ago
Reuters, 1 month ago
First Post.com, 1 month ago
Deccan Chronicle, 3 months ago
Financial Chronicle, 2 months ago
India Infoline, 3 months ago
Financial Express, 3 months ago
Livemint.com

BUZZ-India's Sun Pharma rises; Credit Suisse says Ranbaxy drug prices hiked

** Sun Pharmaceutical Industries gains 1 pct ** Company hikes prices in unit Ranbaxy Laboratories' US-branded portfolio - Credit Suisse ** Earnings could increase by 2-3 pct - Credit Suisse
 Reuters India3 days ago Sun Pharma-Ranbaxy: honeymoon over, now to make it work  HT Syndication1 month ago Sun Pharma-Ranbaxy merger: honeymoon over, now to make it work  Livemint.com1 month ago India's Sun Pharma misses profit estimates on Ranbaxy costs  Reuters India1 month ago
[x]  
Sify

Sun Pharma Axes 18 Top Ranbaxy Laboratories Executives

June 18, 2015 By Alex Keown , BioSpace.com Breaking News Staff MUMBAI, India Eighteen executives at Ranbaxy Laboratories , including Indrajit Banerjee , the company president and chief financial officer, were terminated by parent company Sun ...
 BioSpace2 weeks ago India's Ranbaxy sued in US for manipulating FDA rules  Business Today India1 month ago Ranbaxy sued for manipulating USFDA rules  Times of India1 month ago US Class Action Asserts Ranbaxy Manipulated FDA Rules  NDTV Profit1 month ago
[x]  

Sun purges 18 Ranbaxy execs in integration move

Weeks after Sun Pharmaceutical completed its acquisition of troubled Ranbaxy Laboratories, 18 top execs have reportedly been given their
 FiercePharmaManufacturing2 weeks ago Sun Pharma dispatches 18 top Ranbaxy execs in post-merger shift  FiercePharma2 weeks ago Sun Pharma stock hits 52-week high  India Infoline2 months ago
Moneycontrol.com

Pharma's struggle to cope standards paves way for MA deals

I Two years after its most high-profile regulatory setback to date in the United States - Ranbaxy 's USD 500 million US fine for drug safety violations - India's USD 15 billion a year generic drug industry is still rebuilding its image in its ...
 Moneycontrol.com4 days ago Indian pharma's struggle to tighten standards paves way for M&A deals  4 Traders4 days ago
Sify

Stock markets rangebound; IT firms fall, Sun Pharma shines

MUMBAI (Reuters) - India's stock markets traded rangebound on Tuesday as software exporters such as Tata Consultancy Services fell after revenue warnings by some of its smaller rivals, while Sun Pharmaceutical Industries rose after Credit Suisse ...
 Sify2 days ago Indian shares rangebound; IT firms fall, Sun Pharma shines  Sify2 days ago
Global Information Inc

Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019

Coming into being in the 1980s, penem is an unsatured beta-lactam featuring broad spectrum, strong effect and low resistance rate. Actually it is the most potent antibiotic with the broadest antibacterial spectrum hitherto. And Imipenem cilastatin ...
 Global Information Inc3 days ago

Some Indian drugmakers see M&A preferable to investing in plant upgrades

'; if(pArray.length >= 4) { i=2; } else if(pArray.length >= 3) { i=2; inline = ''; } else if(pArray.length >= 2) { i=1; inline = ''; } else if(pArray.length === 1) { i=0; inline = ''; } $('#librarydrawer_story_container script').each(function() { ...
 FiercePharmaManufacturing3 days ago Tougher regulations force Indian drugmakers to invest or divest  FiercePharma3 days ago Generics maker Alvogen eyes faster growth after CVC-led buyout  FiercePharma1 week ago Starbucks India faces the heat; Public concern over food safety  Tehelka2 weeks ago
[x]  

Tighter drug quality norms, price controls open route to M&A deals

Stricter drug quality norms, especially in the United States, the major market for India's generic pharmaceutical products, and price controls in India are forcing smaller generic drugmakers in the country to look for an exit route. Amidst ...
 Domain-B3 days ago
Bangladesh Daily Star

Beximco launches copy of blockbuster hepatitis C drug

BEXIMCO Pharma yesterday announced the launch of the generic version of the wonder drug Sofosbuvir for treating hepatitis C under the brand name Sofovir C. Sofosbuvir is a revolutionary drug recently launched by Gilead Sciences Inc, under its ...
 Bangladesh Daily Star3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less